|
Volumn 12, Issue 2, 2003, Pages
|
Off-label or out of bounds? Prescriber and marketer liability for unapproved uses of FDA-approved drugs.
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARTICLE;
CONSUMER;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG LABELING;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LEGAL ASPECT;
LEGAL LIABILITY;
MARKETING;
POLITICS;
PRESCRIPTION;
SAFETY;
STANDARD;
TREATMENT OUTCOME;
UNITED STATES;
CONSUMER ORGANIZATIONS;
CONSUMER PRODUCT SAFETY;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG LABELING;
HUMANS;
INVESTIGATIONAL NEW DRUG APPLICATION;
LIABILITY, LEGAL;
LOBBYING;
MARKETING;
PRESCRIPTIONS, DRUG;
TREATMENT OUTCOME;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 0042512222
PISSN: 10752994
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (41)
|
References (0)
|